EGLN2 and cancer: Several studies examined the role of EGLN2 4-bp ins/del polymorphism and the risk of some cancers (Zhu et al., 2012; Che et al., 2014; Wang et al., 2014; Li et al., 2017; Hashemi et al., 2018b; Zhu et al., 2018).